DK1344533T3 - Farmaceutiske præparater, der omfatter mannosebindende lectin - Google Patents
Farmaceutiske præparater, der omfatter mannosebindende lectinInfo
- Publication number
- DK1344533T3 DK1344533T3 DK03388016T DK03388016T DK1344533T3 DK 1344533 T3 DK1344533 T3 DK 1344533T3 DK 03388016 T DK03388016 T DK 03388016T DK 03388016 T DK03388016 T DK 03388016T DK 1344533 T3 DK1344533 T3 DK 1344533T3
- Authority
- DK
- Denmark
- Prior art keywords
- mbl
- pharmaceutical compositions
- binding lectin
- compositions
- variants
- Prior art date
Links
- 102000009112 Mannose-Binding Lectin Human genes 0.000 title abstract 11
- 108010087870 Mannose-Binding Lectin Proteins 0.000 title abstract 11
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 150000001768 cations Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/482—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200200414 | 2002-03-15 | ||
| PCT/DK2003/000179 WO2003077937A1 (en) | 2002-03-15 | 2003-03-14 | Pharmaceutical compositions comprising mannose binding lectin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1344533T3 true DK1344533T3 (da) | 2007-01-08 |
Family
ID=27763313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK03388016T DK1344533T3 (da) | 2002-03-15 | 2003-03-14 | Farmaceutiske præparater, der omfatter mannosebindende lectin |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7462596B2 (enExample) |
| EP (1) | EP1344533B1 (enExample) |
| JP (1) | JP2005526084A (enExample) |
| CN (1) | CN1652813A (enExample) |
| AT (1) | ATE337014T1 (enExample) |
| AU (1) | AU2003215524A1 (enExample) |
| DE (1) | DE60307701T2 (enExample) |
| DK (1) | DK1344533T3 (enExample) |
| ES (1) | ES2271515T3 (enExample) |
| PT (1) | PT1344533E (enExample) |
| WO (1) | WO2003077937A1 (enExample) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003002136A2 (en) | 2001-06-28 | 2003-01-09 | Novo Nordisk A/S | Stable formulation of modified glp-1 |
| GB0222014D0 (en) * | 2002-09-23 | 2002-10-30 | Leuven K U Res & Dev | Mannan-binding lectin |
| KR101308912B1 (ko) | 2003-06-03 | 2013-09-23 | 노보 노르디스크 에이/에스 | 안정화된 약학적 펩티드 조성물 |
| PL1633391T3 (pl) | 2003-06-03 | 2012-03-30 | Novo Nordisk As | Stabilizowane farmaceutycznie kompozycje peptydowe |
| DK3300721T4 (da) | 2003-11-20 | 2025-03-03 | Novo Nordisk As | Propylenglycol-holdige peptidformuleringer hvilke er optimale til fremstilling og til anvendelse i injektionsindretninger |
| US7335633B2 (en) * | 2004-01-12 | 2008-02-26 | Cornell Research Foundation, Inc. | Detecting recurrent vulvovaginal candidiasis or vulvar vestibulitis syndrome and method for treating same |
| EP1618887A1 (en) * | 2004-07-12 | 2006-01-25 | UMC Utrecht Holding B.V. | Clearance of polyols from the body |
| PL1789434T3 (pl) | 2004-08-31 | 2014-07-31 | Novo Nordisk As | Zastosowanie tris(hydroksymetylo)aminometanu do stabilizacji peptydów, polipeptydów i białek |
| MX2007005521A (es) | 2004-11-12 | 2007-05-18 | Novo Nordisk As | Formulaciones estables de peptidos insulinotropicos. |
| WO2006071102A1 (en) * | 2004-12-30 | 2006-07-06 | Dobeel Co., Ltd. | Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same |
| EP1874333A2 (en) * | 2005-04-11 | 2008-01-09 | Natimmune A/S | Mannan-binding lectin (mbl) in the treatment of immunocompromised conditions asssociated with cancer |
| TW200727900A (en) * | 2005-07-27 | 2007-08-01 | Yakult Honsha Kk | Aqueous solution preparation containing camptothecins |
| US20090304686A1 (en) * | 2006-03-08 | 2009-12-10 | Universotair Medisch Centrum Utrecht | Interfering in activation of an immune cell by influencing interaction of lair and collagen |
| HRP20160625T1 (hr) * | 2007-09-10 | 2016-08-12 | Boston Biomedical, Inc. | Novi inhibitori stat3 signalnog puta i inhibitori matičnih stanica raka |
| GB0821806D0 (en) * | 2008-11-28 | 2009-01-07 | Circassia Ltd | Compositions with reduced dimer formation |
| US20120282285A1 (en) | 2009-07-17 | 2012-11-08 | Rigshospitalet | Masp isoforms as inhibitors of complement activation |
| SG10201503351RA (en) | 2010-01-19 | 2015-06-29 | Harvard College | Engineered Opsonin for Pathogen Detection and Treatment |
| ES2987670T3 (es) | 2010-03-19 | 2024-11-15 | 1Globe Biomedical Co Ltd | Métodos novedosos para actuar sobre células madre cancerosas |
| AU2012284097B2 (en) | 2011-07-18 | 2017-08-03 | President And Fellows Of Harvard College | Engineered microbe-targeting molecules and uses thereof |
| WO2013130875A1 (en) | 2012-02-29 | 2013-09-06 | President And Fellows Of Harvard College | Rapid antibiotic susceptibility testing |
| BR112014031522A2 (pt) * | 2012-06-18 | 2017-08-01 | Omeros Corp | métodos para inibir a ativação de complemento dependente de masp-3, para inibir a ativação de complemento dependente de masp-2 e para fabricar um medicamento |
| WO2014144325A1 (en) | 2013-03-15 | 2014-09-18 | President And Fellows Of Harvard College | Methods and compositions for improving detection and/or capture of a target entity |
| CA2908380A1 (en) | 2013-04-09 | 2014-10-16 | Boston Biomedical, Inc. | Methods for treating cancer |
| JP6649250B2 (ja) | 2013-05-21 | 2020-02-19 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 操作されたヘム結合性構成物およびその使用 |
| US10513546B2 (en) | 2013-12-18 | 2019-12-24 | President And Fellows Of Harvard College | CRP capture/detection of gram positive bacteria |
| EP3331549B1 (en) | 2015-08-06 | 2020-12-23 | President and Fellows of Harvard College | Improved microbe-binding molecules and uses thereof |
| WO2018102427A1 (en) | 2016-11-29 | 2018-06-07 | Boston Biomedical, Inc. | Naphthofuran derivatives, preparation, and methods of use thereof |
| WO2018213424A1 (en) | 2017-05-17 | 2018-11-22 | Boston Biomedical, Inc. | Methods for treating cancer |
| KR102665710B1 (ko) | 2017-08-24 | 2024-05-14 | 노보 노르디스크 에이/에스 | Glp-1 조성물 및 그 용도 |
| CN110755601B (zh) * | 2019-10-31 | 2023-06-23 | 云南康洲生物科技有限公司 | 一种治疗hiv/aids免疫重建缺陷的芸豆凝集素植物药组合物和制备方法及其应用 |
| JP7761567B2 (ja) | 2020-02-18 | 2025-10-28 | ノヴォ ノルディスク アー／エス | 医薬製剤 |
| JP2024537924A (ja) * | 2021-10-01 | 2024-10-16 | インスティテュート オブ ケミストリー、テクノロジー アンド メタラジー | サバリア・サバグリアの炭水化物結合ポリペプチド |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4707231B2 (ja) * | 1998-06-10 | 2011-06-22 | スタテンズ セーラム インスティテュート | マンナン結合レクチンを製造するための精製方法及びｍｂｌ医薬品 |
| DK1084143T3 (da) * | 1998-06-10 | 2006-12-27 | Statens Seruminstitut | Oprensningsproces til fremstilling af mannanbindende lectin og et medicinsk MBL-produkt |
| US6297024B1 (en) * | 1998-10-15 | 2001-10-02 | Cell Activation, Inc. | Methods for assessing complement activation |
| DE60030173T2 (de) * | 1999-05-14 | 2007-08-23 | Steffen Thiel | Neue Indikationen für Mannan-binding Lectin (MBL) zur Behandlung von immungeschwächten Patienten |
| US7211396B2 (en) * | 2002-04-18 | 2007-05-01 | Antibodyshop A/S | Antibody pairs and kits for immunochemical determination of mannan-binding lectin |
-
2003
- 2003-03-14 AU AU2003215524A patent/AU2003215524A1/en not_active Abandoned
- 2003-03-14 DE DE60307701T patent/DE60307701T2/de not_active Expired - Fee Related
- 2003-03-14 PT PT03388016T patent/PT1344533E/pt unknown
- 2003-03-14 JP JP2003575990A patent/JP2005526084A/ja active Pending
- 2003-03-14 EP EP03388016A patent/EP1344533B1/en not_active Expired - Lifetime
- 2003-03-14 US US10/388,322 patent/US7462596B2/en not_active Expired - Fee Related
- 2003-03-14 CN CNA038105802A patent/CN1652813A/zh active Pending
- 2003-03-14 ES ES03388016T patent/ES2271515T3/es not_active Expired - Lifetime
- 2003-03-14 WO PCT/DK2003/000179 patent/WO2003077937A1/en not_active Ceased
- 2003-03-14 DK DK03388016T patent/DK1344533T3/da active
- 2003-03-14 AT AT03388016T patent/ATE337014T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| PT1344533E (pt) | 2007-01-31 |
| US7462596B2 (en) | 2008-12-09 |
| ATE337014T1 (de) | 2006-09-15 |
| US20040006009A1 (en) | 2004-01-08 |
| EP1344533B1 (en) | 2006-08-23 |
| DE60307701D1 (de) | 2006-10-05 |
| DE60307701T2 (de) | 2007-10-11 |
| AU2003215524A1 (en) | 2003-09-29 |
| EP1344533A1 (en) | 2003-09-17 |
| CN1652813A (zh) | 2005-08-10 |
| JP2005526084A (ja) | 2005-09-02 |
| ES2271515T3 (es) | 2007-04-16 |
| WO2003077937A1 (en) | 2003-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1344533T3 (da) | Farmaceutiske præparater, der omfatter mannosebindende lectin | |
| IL203923A (en) | Benzamide compounds, pharmaceutical compositions comprising them, use thereof in the preparation of medicaments and as medicaments and processes for the preparation of such compounds | |
| CA2319308A1 (en) | Pharmaceutical agents | |
| BR9914360A (pt) | N-aralquilaminotetralinas como ligandos para oreceptor neuropeptìdeo yy5 | |
| EA200800056A1 (ru) | Каннабиноидный активный фармацевтический ингредиент для лекарственных форм | |
| PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
| BR0311313A (pt) | Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase | |
| CA2534798A1 (en) | Thiazole derivatives as cannabinoid receptor modulators | |
| ATE429210T1 (de) | Orale flüssige zusammensetzungen | |
| NO20042298L (no) | Farmasoytiske preparater og deres anvendelser | |
| BR0210711A (pt) | Uso de um composto, composição farmacêutica, composto, e, processo para a preparação de um composto | |
| EE200300370A (et) | Atsüülitud 6,7,8,9-tetrahüdro-5H-bensotsükloheptenüülamiinid, nende valmistamismeetod, kasutamine ja farmatseutiline preparaat | |
| BR9910583A (pt) | Aminotetralinas n-substituìdas como ligantes para o receptor de neuropeptìdeo y y5 úteis no tratamento de obesidade e outros distúrbios | |
| DK0733046T3 (da) | Benzoylguanidiner, deres fremstilling og anvendelse i medikamenter | |
| ATE323766T1 (de) | Glykosylierte leptinzusammensetzungen und zugehörige verfahren | |
| SE0302139D0 (sv) | Novel compounds | |
| ATE549353T1 (de) | Aktive varianten des il-18 bindenden proteins und dessen medizinische verwendungen | |
| PT1057828E (pt) | Suspensoes de trovafloxacina para administracao oral | |
| DK1651270T3 (da) | Medikamenter til inhalation omfattende betamimetika og et anticholinergikum | |
| WO2003050067A3 (fr) | Analogues de la vitamine d | |
| HUP0401325A3 (en) | Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds | |
| ATE213233T1 (de) | Substituierte caprolactame und deren derivate verwendbar zur behandlung der hiv-krankheit | |
| CY1106552T1 (el) | Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς | |
| WO2004031222A3 (en) | Dna vaccine encoding at least two nonstructural early proteins of papillomavirus | |
| WO2007118687A3 (en) | Use of staphylococcal superantigen-like protein 5 (ssl5) in medicine |